V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008661 | 220011911 | 1.52 | 91 | Curative (C) | 2017-12-03 | 2017-12-04 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034968 | ADE |
| 220008662 | 220011911 | 1.68 | 95.2 | Palliative (P) | 2013-07-09 | 2013-07-11 | Gemcitabine 1000mg/m2 D1 8 15 | 99 | N | 220034968 | RITUXIMAB |
| 220008663 | 220003494 | 1.61 | 60 | Palliative (P) | 2017-03-26 | 2017-04-13 | EOX | N | N | 220034972 | EOX |
| 220008664 | 220003495 | 1.86 | null | Palliative (P) | 2013-08-18 | 2013-08-20 | PEMBROLIZUMAB | 2 | N | 220034975 | RAVVA TRIAL |
| 220008665 | 220003495 | 1.55 | 78.2 | Palliative (P) | 2014-06-14 | 2014-07-05 | Capecitabine + Oxaliplatin 21day | 2 | N | 220034975 | CAPECITABINE + OXALIPLATIN |
| 220008666 | 220003495 | 1.57 | 52 | Palliative (P) | 2017-02-28 | 2017-03-04 | FLAG | N | null | 220034975 | FLAG |
| 220008667 | 220019002 | 1.79 | 67.3 | Curative (C) | 2017-09-17 | 2017-09-18 | ADE 8+3+5 | 02 | N | 220034979 | ADE |
| 220008669 | 220003497 | 1.73 | 17.2 | Palliative (P) | 2016-10-11 | 2016-10-11 | CARBOPLATIN | 2 | N | 220034986 | CARBOPLATIN |
| 220008670 | 220003497 | 1.63 | 73 | Palliative (P) | null | 2015-11-05 | ECX | N | N | 220034986 | ECX |
| 220008671 | 220003497 | null | 74 | Neo-adjuvant (N) | null | 2016-09-07 | Carboplatin AUC 2 - 5 | N | null | 220034986 | CARBOPLATIN |
| 220008672 | 220003498 | 1.74 | 88 | null | 2016-11-20 | 2016-11-25 | Cisplatin + Radiotherapy | N | N | 220034990 | CISPLATIN + RT |
| 220008673 | 220003499 | 1.73 | null | Palliative (P) | 2014-09-27 | 2015-07-15 | RAVVA TRIAL | N | N | 220034991 | RAVVA TRIAL |
| 220008674 | 220011914 | 1.6 | 47 | Neo-adjuvant (N) | null | 2014-09-15 | Oxaliplatin + Modified de Gramont | N | N | 220034992 | OXALIPLATIN + MDG |
| 220008675 | 220003500 | null | 83 | null | null | 2018-03-11 | Cisplatin + Radiotherapy | N | N | 220034995 | CISPLATIN + RT |
| 220008676 | 220003501 | null | 66.9 | Palliative (P) | 2014-03-28 | 2014-05-30 | RAVVA TRIAL | N | null | 220034996 | GEMCITABINE |
| 220008677 | 220003502 | 1.73 | 51 | Curative (C) | 2016-09-14 | 2016-12-04 | AML Int Guide HD Cytarabine (3 + 4) | 02 | N | 220034999 | CYTARABINE HIGH DOSE |
| 220008678 | 220003502 | 1.5 | 96 | Palliative (P) | 2017-07-20 | 2017-07-22 | EOX | 1 | N | 220034999 | EOX |
| 220008679 | 220003502 | 1.62 | 54.4 | null | 2014-09-18 | 2014-10-03 | ECX | 02 | N | 220034999 | ECX |
| 220008680 | 220003502 | 1.64 | 88 | Palliative (P) | 2015-03-16 | 2015-03-23 | Capecitabine + Oxaliplatin 14day | Y | N | 220034999 | CAPECITABINE + OXALIPLATIN |
| 220008681 | 220003502 | 1.8 | 99.3 | Palliative (P) | 2016-03-27 | 2016-04-23 | EOX | 01 | N | 220034999 | EOX |
| 220008682 | 220003502 | 1.71 | 77.8 | Palliative (P) | 2016-04-20 | 2016-04-22 | RAVVA TRIAL | N | Y | 220034999 | RITUXIMAB |
| 220008683 | 220003503 | 1.58 | 58 | Curative (C) | 2017-08-19 | 2017-08-21 | AML Int Guide ADE 10+3+5 (1) | N | N | 220035017 | ADE |
| 220008684 | 220003503 | 1.79 | 102 | Not known (9) | 2013-06-28 | 2013-07-11 | Cytarabine High Dose | N | N | 220035017 | CYTARABINE HIGH DOSE |
| 220008685 | 220003503 | 1.6 | 21.5 | null | 2012-12-03 | 2012-12-03 | Carboplatin AUC 6 - 10 | N | N | 220035017 | CARBOPLATIN |
| 220008686 | 220003504 | 1.72 | 75 | Curative (C) | 2017-08-18 | 2017-09-21 | Cytarabine High Dose | N | N | 220035032 | CYTARABINE HIGH DOSE |
| 220008687 | 220003505 | null | null | Curative (C) | 2014-05-23 | 2014-06-06 | CISPLATIN + RT | 02 | N | 220035033 | CISPLATIN + RT |
| 220008688 | 220003506 | 1.54 | 16.2 | Neo-adjuvant (N) | 2017-09-19 | 2017-10-05 | ECX | N | N | 220035036 | ECX |
| 220008689 | 220003507 | 1.8 | 69.6 | Palliative (P) | 2013-05-30 | 2013-05-31 | ECX | N | null | 220035037 | ECX |
| 220008690 | 220003507 | null | 72.7 | Palliative (P) | 2013-01-19 | 2013-01-23 | EOX | N | N | 220035037 | EOX |
| 220008691 | 220003507 | null | 69 | Curative (C) | 2017-06-28 | 2017-06-28 | AML Int Guide ADE 10+3+5 (1) | N | null | 220035037 | ADE |
| 220008692 | 220003507 | 1.82 | 15 | Adjuvant (A) | 2017-07-06 | 2017-07-06 | Cisplatin + Radiotherapy | N | N | 220035037 | CISPLATIN + RT |
| 220008694 | 220003509 | 1.81 | 101.6 | Palliative (P) | 2013-08-17 | 2013-08-17 | Carboplatin + Etoposide IV 3 day | 2 | N | 220035054 | CARBOPLATIN + ETOPOSIDE |
| 220008695 | 220003510 | 1.72 | 48.8 | 1 | 2014-04-28 | 2014-05-18 | CISPLATIN + RT | N | N | 220035056 | CISPLATIN + RT |
| 220008696 | 220011918 | 1.65 | 64 | null | 2017-04-19 | 2017-06-23 | Carboplatin AUC 2 - 5 | N | N | 220035058 | CARBOPLATIN |
| 220008698 | 220003512 | 0 | 8.5 | Palliative (P) | null | 2013-11-14 | ECX | 02 | N | 220035060 | ECX |
| 220008699 | 220003512 | null | null | Palliative (P) | null | 2017-05-19 | RAVVA TRIAL | N | N | 220035060 | RITUXIMAB |
| 220008704 | 220003514 | null | 103.6 | Palliative (P) | 2013-12-25 | 2013-12-29 | Carboplatin + Etoposide iv&po | N | N | 220035069 | CARBOPLATIN + ETOPOSIDE |
| 220008705 | 220003515 | 1.78 | 72.3 | Palliative (P) | 2013-03-23 | 2013-03-23 | FLUOROURACIL + OXALIPLATIN | null | N | 220035072 | OXALIPLATIN + MDG |
| 220008706 | 220003515 | 1.65 | 60.9 | Palliative (P) | null | 2014-07-17 | EOX | N | N | 220035072 | EOX |
| 220008707 | 220003515 | null | 80 | Palliative (P) | 2016-11-03 | 2016-11-09 | CARBOPLATIN + ETOPOSIDE | N | N | 220035072 | CARBOPLATIN + ETOPOSIDE |
| 220008708 | 220003515 | null | 54.4 | null | 2015-01-20 | 2015-01-20 | GEMCITABINE | N | N | 220035072 | PEMBROLIZUMAB |
| 220008709 | 220003515 | 1.67 | 80.9 | Palliative (P) | 2014-06-19 | 2014-06-22 | Carboplatin AUC 2 - 5 | N | null | 220035072 | CARBOPLATIN |
| 220008710 | 220003516 | 1.62 | 57.4 | Not known (9) | 2015-04-27 | 2015-06-08 | ECX | N | N | 220035085 | ECX |
| 220008711 | 220003516 | null | null | Palliative (P) | 2017-03-11 | 2017-03-26 | EOX | N | N | 220035085 | EOX |
| 220008712 | 220003516 | 1.63 | 9.2 | Palliative (P) | 2016-04-26 | 2016-04-28 | RAVVA TRIAL | 02 | N | 220035085 | RITUXIMAB |
| 220008713 | 220003516 | 1.63 | 26.4 | Palliative (P) | 2015-06-27 | 2015-07-27 | CARBOPLATIN + ETOPOSIDE | 2 | N | 220035085 | CARBOPLATIN + ETOPOSIDE |
| 220008714 | 220003517 | 1.77 | null | Curative (C) | null | 2016-07-08 | AML Int Guide ADE 10+3+5 (1) | 01 | N | 220035095 | ADE |
| 220008715 | 220003518 | 1.76 | 46.3 | Palliative (P) | 2017-08-26 | 2017-08-26 | Carboplatin + Etoposide IV 3 day | N | N | 220035097 | CARBOPLATIN + ETOPOSIDE |
| 220008717 | 220003520 | null | null | Curative (C) | 2016-08-09 | 2016-08-09 | AML Int Guide ADE 10+3+5 (1) | N | N | 220035101 | ADE |
| 220008718 | 220003520 | 0.99 | 79.4 | Palliative (P) | 2013-04-23 | 2013-04-23 | ECX | N | null | 220035101 | ECX |